
John Husar
Examiner (ID: 11562)
| Most Active Art Unit | 3725 |
| Art Unit(s) | 3204, 3206, 3725, 3209 |
| Total Applications | 1063 |
| Issued Applications | 957 |
| Pending Applications | 45 |
| Abandoned Applications | 61 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20158132
[patent_doc_number] => 12384743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/066000
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1034
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18066000
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/066000 | Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof | Dec 13, 2022 | Issued |
Array
(
[id] => 18484802
[patent_doc_number] => 20230212108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => LINEAR CARBONATE AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/080682
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080682
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/080682 | LINEAR CARBONATE AND PREPARATION METHOD THEREOF | Dec 12, 2022 | Pending |
Array
(
[id] => 19281502
[patent_doc_number] => 20240217976
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2024-07-04
[patent_title] => COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/063331
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 361
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063331 | Compound and polymer compound containing the compound | Dec 7, 2022 | Issued |
Array
(
[id] => 19281502
[patent_doc_number] => 20240217976
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2024-07-04
[patent_title] => COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/063331
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 361
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063331 | Compound and polymer compound containing the compound | Dec 7, 2022 | Issued |
Array
(
[id] => 18299015
[patent_doc_number] => 20230108701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => TRANSITION METAL COMPLEXES COMPRISING CARBENE LIGANDS SERVING AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLED'S)
[patent_app_type] => utility
[patent_app_number] => 18/061111
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061111
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061111 | TRANSITION METAL COMPLEXES COMPRISING CARBENE LIGANDS SERVING AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLED'S) | Dec 1, 2022 | Abandoned |
Array
(
[id] => 18420054
[patent_doc_number] => 20230174515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/073728
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18073728
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/073728 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Dec 1, 2022 | Issued |
Array
(
[id] => 19020110
[patent_doc_number] => 20240076281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
[patent_app_type] => utility
[patent_app_number] => 18/070408
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070408
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070408 | TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Nov 27, 2022 | Abandoned |
Array
(
[id] => 18675026
[patent_doc_number] => 20230312575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => LIGANDS TO CEREBLON (CRBN)
[patent_app_type] => utility
[patent_app_number] => 17/985415
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985415 | Ligands to cereblon (CRBN) | Nov 10, 2022 | Issued |
Array
(
[id] => 18628131
[patent_doc_number] => 20230286961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS
[patent_app_type] => utility
[patent_app_number] => 17/982983
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982983 | Substituted tetrahydrofurans as modulators of sodium channels | Nov 7, 2022 | Issued |
Array
(
[id] => 19311518
[patent_doc_number] => 12037321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => 1,2,4-oxadiazole derivatives as immunomodulators
[patent_app_type] => utility
[patent_app_number] => 17/981695
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7845
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17981695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/981695 | 1,2,4-oxadiazole derivatives as immunomodulators | Nov 6, 2022 | Issued |
Array
(
[id] => 18980109
[patent_doc_number] => 11905269
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-02-20
[patent_title] => Crown ether carbenes and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/981201
[patent_app_country] => US
[patent_app_date] => 2022-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7425
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17981201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/981201 | Crown ether carbenes and methods of use | Nov 3, 2022 | Issued |
Array
(
[id] => 18701278
[patent_doc_number] => 11787777
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-17
[patent_title] => Crown ether amines and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/981162
[patent_app_country] => US
[patent_app_date] => 2022-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7250
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17981162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/981162 | Crown ether amines and methods of use | Nov 3, 2022 | Issued |
Array
(
[id] => 18468761
[patent_doc_number] => 20230203043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => NOVEL IMIDAZOPYRAZINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/976651
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17976651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/976651 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | Oct 27, 2022 | Pending |
Array
(
[id] => 18363459
[patent_doc_number] => 20230145050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/967599
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17967599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/967599 | Sulphonyl urea derivatives as NLRP3 inflammasome modulators | Oct 16, 2022 | Issued |
Array
(
[id] => 18675045
[patent_doc_number] => 20230312599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => ALDOSE REDUCTASE INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/046205
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046205
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046205 | Aldose reductase inhibitors and methods of use thereof | Oct 12, 2022 | Issued |
Array
(
[id] => 18626794
[patent_doc_number] => 20230285603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/963823
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/963823 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | Oct 10, 2022 | Issued |
Array
(
[id] => 18225191
[patent_doc_number] => 20230064185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS AND COMPOSITIONS FOR TERPENOID TRICYCLOALKANE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/950772
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/950772 | Methods and compositions for terpenoid tricycloalkane synthesis | Sep 21, 2022 | Issued |
Array
(
[id] => 20173034
[patent_doc_number] => 12391767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Antibodies to symmetrically dimethylated arginine analytes and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/946908
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 20458
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946908 | Antibodies to symmetrically dimethylated arginine analytes and use thereof | Sep 15, 2022 | Issued |
Array
(
[id] => 19948334
[patent_doc_number] => 12319681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Tripartite androgen receptor eliminators, methods and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/931773
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41919
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931773 | Tripartite androgen receptor eliminators, methods and uses thereof | Sep 12, 2022 | Issued |
Array
(
[id] => 19651206
[patent_doc_number] => 12172974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Prodrugs of riluzole and their method of use
[patent_app_type] => utility
[patent_app_number] => 17/940287
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16201
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940287
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940287 | Prodrugs of riluzole and their method of use | Sep 7, 2022 | Issued |